Wells Fargo & Company Selecta Biosciences Inc Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Wells Fargo & Company holds 40,260 shares of SELB stock, worth $33,818. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,260

Previous 35,192 14.4%

Holding current value

$33,818

Previous $24,000 37.5%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.62 - $0.85 $3,142 - $4,307	5,068 Added 14.4%	40,260 $33,000
Q4 2023 Feb 09, 2024	BUY	$0.67 - $1.35 $4,951 - $9,977	7,391 Added 26.59%	35,192 $24,000
Q3 2023 Nov 13, 2023	SELL	$1.02 - $1.23 $18,470 - $22,272	-18,108 Reduced 39.44%	27,801 $29,000
Q2 2023 Aug 15, 2023	BUY	$1.04 - $1.4 $46,321 - $62,355	44,540 Added 3253.47%	45,909 $51,000
Q1 2023 May 12, 2023	BUY	$1.15 - $1.89 $675 - $1,109	587 Added 75.06%	1,369 $1,000

Q4 2022 Feb 13, 2023	BUY	$0.96 - $1.6 $20 - $33	21 Added 2.76%	782 $0
Q3 2022 Nov 14, 2022	SELL	$1.33 - $2.6 $122 - $239	-92 Reduced 10.79%	761 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.67 - $1.4 $60,992 - $127,447	-91,034 Reduced 99.07%	853 $1,000
Q1 2022 May 16, 2022	SELL	$1.23 - $3.31 $30,778 - $82,826	-25,023 Reduced 21.4%	91,887 $113,000
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.43 $66,181 - $101,447	-22,900 Reduced 16.38%	116,910 $381,000
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.62 $285,542 - $392,621	84,983 Added 155.0%	139,810 $581,000
Q2 2021 Aug 16, 2021	BUY	$2.82 - $5.01 $89,690 - $159,343	31,805 Added 138.15%	54,827 $229,000
Q1 2021 May 13, 2021	SELL	$2.92 - $5.07 $270,251 - $469,238	-92,552 Reduced 80.08%	23,022 $105,000
Q4 2020 Feb 09, 2021	SELL	$1.64 - $3.42 $71,523 - $149,153	-43,612 Reduced 27.4%	115,574 $350,000
Q3 2020 Nov 05, 2020	BUY	$2.18 - $2.84 $72,685 - $94,691	33,342 Added 26.49%	159,186 $394,000
Q2 2020 Aug 13, 2020	BUY	$1.83 - $4.06 $229,946 - $510,155	125,654 Added 66133.68%	125,844 $357,000
Q1 2020 May 14, 2020	BUY	$1.5 - $4.52 $285 - $858	190 New	190 $0

Others Institutions Holding SELB

# of Institutions

Shares Held

41.3M

Call Options Held

16.8K

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Selecta Biosciences Inc Transaction History